Pear Bio
Patient-centered Cancer Precision Medicine
Natick, United States · Founded 2017
- Headquarters
- Natick, Massachusetts
- Employees
- 11–50
- Founded
- 2017
- Business Model
- B2B
- Website
- pearbio.com
- Last Round
- Series AApr 2023
- Rounds
- 2
About
Pear Bio is a functional precision medicine company that develops personalized cancer treatment tests and novel therapeutics. The platform takes tumor biopsies from patients, converts them into 3D immune-microtumors, and tests multiple treatment options side-by-side to predict response and match patients with effective therapies. Excess tissue is characterized to identify new drug targets for cancers with high unmet need. Founded in 2017, Pear Bio serves both oncology drug discovery teams and individual cancer patients through its personalized testing services and computational biology platform.
Summary
Pear Bio is a company based in Natick, United States, founded in 2017. Its most recent funding was a Series A round in Apr 2023. Investors include SOSV, octopus investments and Hoxton Ventures.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Apr 2023
Sign up to see all 2 rounds
Grant through Series A — per-round amounts, valuations, and who invested in each round.
Investors
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/pear-bio"><img src="https://indexed.vc/api/badge/company/pear-bio" alt="Pear Bio on Indexed.vc" width="260" height="76" /></a>